Up to Half of Gestational Diabetes Patients Will Develop Diabetes Type 2
A recent study published in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM) published a study “Clinical and Genetic Risk Factors for Type 2 Diabetes at Early or Late Post Partum After Gestational Diabetes Mellitus”. This study shows that women are more likely at a risk of diabetes 2 when they are pregnant. The study considered 370 participants in a longitudinal study of up to and more than a year following the birth.
Specifically, the studied focused on the HHEX (hematopoietically expressed homeobox) gene , closely related with type 2 diabetes. Those who were slower to develop type 2 diabetes had a variation in the CDKAL1 gene.
Read article from Diabetes Care
Misdiagnosed with Diabetes Type 2
Here is one lady’s story and her journey with diabetes. She discusses how she was misdiagnosed so she kept having health conditions, but no one knew for certain why her health was suffering and what to do. Her doctors have tried to prescribe medications that unfortunately did not work.
Once she did learn what was wrong finally, she started taking the necessary precautions, which have made her life so much easier and better. She talks about when she was younger her brother was diagnosed but she never really learned about his condition as her mother helped her brother. Since then, she has learned about blood sugar levels.
Read her story in Diabetes Daily
Therapeutic Targets Found To Alter Inflammation
The study, published in the Proceedings of the National Academies of Sciences and conducted at Boston University School of Medicine (BUSM), shows that B cells control obesity-associated inflammation and type 2 diabetes. B cells are white blood cells of the immune system, stimulate inflammation and can lead to the development of type 2 diabetes.
Read article from Medical News Daily
Bariatric surgery may help send Type 2 diabetes into remission
Research shows that diabetes patients should have a bariatric surgery, as it may help to put them to reduce their risks associated with Type 2 diabetes.
Research originally came when Cleveland Clinic published “Top 10 Medical Innovations for 2013.”
During the surgery, the digestive tract is changed and the stomach is shrinked to a small pouch. This allows the food to enter the small intestine at a delayed point than before.
Read article from Huffington Post
Read article from Your Daily Journal
Incretin Mimetic Drugs for Type 2 Diabetes: Early Communication – Reports of Possible Increased Risk of Pancreatitis and Pre-cancerous Findings of the Pancreas
FDA is currently assessing claims that that researchers have published about the growth of danger of “pancreatitis and pre-cancerous cellular changes called pancreatic duct metaplasia in patients with type 2 diabetes treated with a class of drugs called incretin mimetics.”
It is recommended for patients to continue to medications as prescribed until further notice.
Read the complete MedWatch Safety Alert
Learn more about the pharmaceutical company focused on the development, manufacture and commercialization of novel compounds: http://www.bostonti.com